The global nanocapsules market size is expected to reach a value of USD 4.89 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.4% from 2024 to 2030. Nanocapsules deliver bioactive molecules by targeted delivery and find application in various industries such as healthcare, genetic engineering, food science and agriculture, cosmetics, agrochemicals, cleansing products, among others. The wide usage of these products across several industries promises lucrative opportunities for the development and commercialization of novel and improved therapies and solutions.
Nanocapsules’ life science applications rely on the ability to achieve controlled and effective release of nano-sized drug carriers to targeted zones. Nanocapsules in the field of healthcare is gaining popularity for its efficient drug targeting. It offers dispersion stability and the quick physiological response and the pyrophoric and oxidation properties are responsible for increased acceptance as an effective agent to diagnose and cure medical disorders. The application of nanotechnology in medicine has been realized to contain important therapeutic benefits, especially in oncology, resulting in the emergence of nano-oncology, a new field involving the chemotherapeutic or diagnostic properties of nanocapsules.
The use of nanotechnology has stretched across various streams of science and has found applications in the field of cosmetics and agriculture. Cosmetic products utilize polymeric nanoparticles (nanospheres and nanocapsules) for efficient topical administration. On the other hand, nanotechnology is recognized to be one of the most important tools in modern agriculture and is anticipated to become a driving factor for strong economic growth in the near future. However, despite the numerous potential advantages of nanotechnology, agricultural applications are scarce in the current scenario and yet to achieve significant market potential. However, recent studies have demonstrated a positive preference for nanocapsules and their respective products and the increasing commercialization of nanotech products with clear benefits will likely drive consumer acceptance of more sensitive applications.
Request a free sample copy or view report summary: Nanocapsules Market Report
Nanocapsules in oncology are engineered to target tumor sites followed by discharge of contents upon a change in conditions.
Rapid development in the fields of pain management and endocrinology with respect to nanocapsule drug delivery is in pipeline and has a high probability of commercialization.
Healthcare dominated the market and accounted for a share of 63.3% in 2023 and is expected to grow at the fastest CAGR over the forecast period
North America and Europe accounted for a collective market share of 60%. this is attributed to the contribution of highly developed countries in increasing R&D and investing activities focusing on the development of novel and highly effective improved therapies involving the use of nanocapsule.
Grand View Research has segmented the global nanocapsules market report based on application, therapeutic area and region:
Nanocapsules Application Outlook (Revenue, USD Million; 2018 - 2030)
Healthcare
Food & Nutraceuticals
Cosmetics
Others
Nanocapsules Therapeutic Area Outlook (Revenue, USD Million; 2018 - 2030)
Oncology
Pain Management
Endocrinology
Others
Nanocapsules Regional Outlook (Revenue, USD Million; 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
APAC
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Nanocapsules Market
BioDelivery Sciences
Camurus
Carlina Technologies
Cerulean Pharma Inc.
Nano Green Sciences, Inc.
NanoNutra
NanoSphere Health Science
Eos Biosciences, Inc.
PolyMicrospheres
GAT Food Essentials
"The quality of research they have done for us has been excellent..."